Vaxart oral vaccine platform advances in late-stage trials
The oral vaccine platform is progressing through late-stage trials across COVID-19, norovirus and flu, with reported positive safety and immunogenicity data and ongoing development supported by partnerships and funding.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.